Market Tracker

10/20 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

21.25
Delayed Data
As of Oct 20
 +0.25 / +1.19%
Today’s Change
7.75
Today|||52-Week Range
25.70
+60.38%
Year-to-Date

Today’s Trading

Previous close21.00
Today’s open21.25
Day’s range20.90 - 21.88
Volume2,749,449
Average volume (3 months)1,787,510
Market cap$1.6B
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-39.77%
Earnings growth (next 5 years)+8.64%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.18-1.59%
RGENRepligen Corp+0.81+2.18%
ARRYArray Biopharma Inc-0.26-2.29%
EBSEmergent BioSolution...+0.28+0.69%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.20
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts